Pellerano instructed on global sale of Hospira Infusion Systems

Pellerano & Herrera advised ICU Medical on the Dominican Republic aspects of its $1 billion global acquisition of Hospira from Pfizer.

ICU Medical, Inc. is headquartered in California and company develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications.

Hospira Infusion Systems is a provider of injectable drugs and infusion technologies and a worldwide leader in biosimilars. Hospira was acquired by Pfizer in 2015 for approximately $17 billion.

Under the current deal, Pfizer secured $600 million in cash from ICU Medical, as well as $400 million in shares from its common stock. Pfizer now owns around 16.6% stake in ICU Medical.

Partners Luis R Pellerano and Mariangela Pellerano led the team at Pellerano & Herrera which advised ICU Medical under Dominican Republic law.

Pfizer instructed Skadden, Arps, Slate, Meagher & Flom and Ropes & Gray for the global deal. The latter firm had advised Pfizer on its 2015 acquisition of Hospira.

ICU Medical retained Latham & Watkins and Baker McKenzie.

Pellerano instructed on global sale of Hospira Infusion Systems

Ignacio Abella

The Latin American Lawyer is a bimonthly digital magazine, published by Iberian Legal Group, available in Spanish and Brazilian Portuguese. It represents the main source of information in the legal business sector in America Latina. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store.

In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors.

For further information, please visit the Group’s website

Iberian Legal Group, S.L.
Registered office: C/ Ríos Rosas 44A - 2 G,H 28003 Madrid España

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram